+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urinary excretion of ursodeoxycholic acid during treatment of patients with primary biliary cirrhosis and primary sclerosing cholangitis



Urinary excretion of ursodeoxycholic acid during treatment of patients with primary biliary cirrhosis and primary sclerosing cholangitis



Journal of Hepatology 7




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 029512618

Download citation: RISBibTeXText

DOI: 10.1016/s0168-8278(88)80425-2


Related references

Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid. Current Gastroenterology Reports 1(1): 38-41, 2000

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis in pregnancy. Hepatology 36(4 Part 2): 491A, 2002

Treatment of the primary biliary cirrhosis and sclerosing cholangitis with ursodeoxycholic acid. Journal of Hepatology 25(Suppl. 1): 210, 1996

Single dose or multiple doses of ursodeoxycholic acid are equally effective in the treatment of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 108(4 Suppl. ): A1191, 1995

Ursodeoxycholic acid therapy plays an immunomodulatory and anti-apoptotic role in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Journal of Hepatology 38(Suppl. 2): 208, 2003

Ursodeoxycholic acid therapy affects the cytokine network and plays an immunomodulatory role in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 36(4 Part 2): 499A, 2002

The effect of ursodeoxycholic acid urso in primary sclerosing cholangitis a comparison to primary biliary cirrhosis. Gastroenterology 94(5 Part 2): A595, 1988

Comparative effects of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis and primary sclerosing cholangitis. Clinical Research 37(2): 365A, 1989

External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid. Hepatology Communications 2(6): 676-682, 2018

Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. Journal of Hepatology 23(3): 283-289, 1995

Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology. 18(2): 298-303, 1993

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. New England Journal of Medicine 336(10): 691-695, 1997

Effects of ursodiol on bile acid metabolism in primary biliary cirrhosis pbc and primary sclerosing cholangitis psc. Williams, C N (Ed ) Falk Symposium, 56 Trends in Inflammatory Bowel Disease Therapy; Symposium, Halifax, Nova Scotia, Canada, June 6-9, 1990 Xviii+462p Kluwer Academic Publishers: Dordrecht, Netherlands; (Dist in The Usa And Canada By Kluwer Academic Publishers: Hingham, Massachusetts, Usa) Illus 423, 1991

Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis. Internal Medicine 39(12): 1049-1053, 2000

Medical Treatment of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Digestion 64(3): 137-150, 2001